Last checked at 
MyHealthChecked PLC - Cardiff, Wales-based consumer home-testing healthcare company - Expects 2023 earnings before interest, tax, depreciation and amortisation to breakeven after recording a first half loss of GBP300,000 and GBP2.3 million profit in 2022. Says full-year revenue is approximately GBP11 million, down from GBP22.3 million a year ago. This results from an "increased seasonal demand" for Covid lateral flow tests during the second half of the year, which continue to account for the majority of the company's revenue. revenue. Cash at December 31 was GBP7.8 million, up 2.6% from GBP7.6 million.
Chief Executive Officer Penny McCormick said: "Our performance in delivering Covid tests in 2023 has been strong. Whilst revenue has, as expected, reduced compared to the prior year, the seasonality of respiratory infections drove an uplift in demand during the second half, and we expect that Covid testing will remain an ongoing annual requirement for customers. Our aim for 2024 is to deliver positively on the investments that have been made so far, while we continue to develop and improve our digital platform."
Current stock price: 14.00 pence, up 3.7%
12-month change: down 33%
By Sabrina Penty, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.